NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,197 filers reported holding NOVARTIS A G in Q3 2023. The put-call ratio across all filers is 1.00 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $818,000 | -6.2% | 9,681 | -2.6% | 0.41% | +9.7% |
| Q1 2022 | $872,000 | +0.3% | 9,936 | 0.0% | 0.37% | +5.1% |
| Q4 2021 | $869,000 | +6.9% | 9,936 | 0.0% | 0.35% | -2.2% |
| Q3 2021 | $813,000 | -10.4% | 9,936 | 0.0% | 0.36% | -9.3% |
| Q2 2021 | $907,000 | +6.8% | 9,936 | 0.0% | 0.40% | +0.5% |
| Q1 2021 | $849,000 | -9.5% | 9,936 | 0.0% | 0.40% | -15.5% |
| Q4 2020 | $938,000 | +8.6% | 9,936 | 0.0% | 0.47% | -1.7% |
| Q3 2020 | $864,000 | -1.7% | 9,936 | -1.2% | 0.48% | -7.7% |
| Q2 2020 | $879,000 | +5.9% | 10,061 | 0.0% | 0.52% | -9.3% |
| Q1 2020 | $830,000 | -16.2% | 10,061 | -3.7% | 0.57% | +47.2% |
| Q4 2019 | $990,000 | +8.7% | 10,451 | -0.3% | 0.39% | +5.1% |
| Q3 2019 | $911,000 | -4.8% | 10,486 | 0.0% | 0.37% | -6.6% |
| Q2 2019 | $957,000 | – | 10,486 | – | 0.40% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Martin Investment Management, LLC | 229,184 | $23,344,682 | 7.00% |
| Foresight Global Investors, Inc. | 97,500 | $9,397,737 | 5.23% |
| SCHARF INVESTMENTS, LLC | 1,425,745 | $145,226,322 | 4.34% |
| MANAGED ASSET PORTFOLIOS, LLC | 274,204 | $27,930,369 | 4.28% |
| GARLAND CAPITAL MANAGEMENT INC | 54,710 | $5,572,761 | 3.93% |
| PRENTISS SMITH & CO INC | 52,032 | $5,299,980 | 3.91% |
| WILKINS INVESTMENT COUNSEL INC | 130,950 | $13,339 | 3.61% |
| First Fiduciary Investment Counsel, Inc. | 145,731 | $14,844 | 3.48% |
| Cullen Capital Management, LLC | 2,714,809 | $276,530,464 | 3.23% |
| JOHN G ULLMAN & ASSOCIATES INC | 182,690 | $18,608,803 | 3.04% |